Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Journal: Lancet

Volume: 

Issue: 

Year of Publication: 2022

Affiliated Institutions: 

Abstract summary 

Authors & Co-authors: 

Study Outcome 

Source Link: Visit source

Statistics
Citations :  2
Authors :  0
Identifiers
Doi : 10.1016/S0140-6736(22)00538-4
SSN : 
Study Population
Male,Female
Mesh Terms
Other Terms
Study Design
Study Approach
Country of Study
Kenya
Publication Country